Novacyt : 2023 Management Report - MarketScreener marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Full year revenue and EBITDA in line with guidance
Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases
. | January 26, 2023
Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases Regulatory News: Novacyt
Significant progress against post-COVID-19 growth strategy to offset expected decline in COVID-19 sales Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist